62th Annual Meeting of the Society of Thrombosis and Haemostasis Research | 20.-23. Februar 2018 in Wien

Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:

180206-A4-Poster2-Druck

An advanced reporting module within the smart medication platform simplifies mandatory reporting into the German Hemophilia Registry (DHR).
A. Rösch, D. Schmoldt, W. Mondorf, Eichler H., Fischer R., VFTH e.V. (Poster Num: P045)

180206-A4-Poster3-Druck

Ensuring information security for the electronic patient diary smart medication by applying an Information Security Management System(ISMS) based on the international standards ISO/IEC 27001 and ISO/IEC 27799.
A. Rösch, D. Schmoldt, W. Mpndorf, Fischer R., VFTH e.V. (Poster Num: P052)

180206-A4-Poster4-Druck

Prophylactic vs. on demand treatment in haemophilia patients – real life data according to electronic diary smart medication.
Fischer R., Eichler H., K. Holstein, R. Klamroth, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes, W. Mondorf, VFTH e.V. (Poster Num: P060)

180206-A4-Poster1-Druck

Bleeding vs. Factor VIII/IX consumption – comparison of annual real-life results between 2014 and 2016 according to electronic diary smart medication.
Mondorf W., Eichler H., Fischer R., Holstein K., Klamroth R., Nimtz-Talaska A., Severin K., Wermes C., VFTH e.V. (Poster Num: P064)